Summary of Key Points
After seven years of development, the STAR Market has transformed from a “test field” for capital market reforms into a hub for high-tech companies. A new round of reforms (expanding listing criteria for cutting-edge fields such as AI and shifting to a technology-based classification system) directly addresses the financing challenges faced by tech startups. However, there are still issues, such as a lack of willingness from early-stage investors to invest in seed rounds and insufficient tolerance for long-term innovation. Experts suggest addressing these challenges by establishing a technology evaluation framework, facilitating the flow of capital, and fostering “patient capital” to ensure that finance serves as a source of “oxygen” rather than a “hormone” for technological innovation.
I. The STAR Market: Seven Years from Experiment to Main Battlefield for High-Tech
What has the STAR Market achieved in these seven years? In short, it has made a breakthrough from scratch:
- Systematically: The registration-based system has accelerated the listing process, eliminating the need for years-long waiting periods.
- Industrially: Hundreds of high-tech companies have become pillars of domestic substitution in sectors like semiconductors and biomedicine, with many seeing revenue growth and becoming leaders in new productivity.
- Economically: The market is attracting more institutional investors who focus on tangible R&D investments rather than mere conceptual hype.
However, there are still challenges: Some companies have not yet turned a profit, and the market lacks tolerance for long-term innovation that may take years to bear fruit.
II. New Reforms Targeting Pain Points
Last month’s reforms at the STAR Market aimed to solve two major problems:
1. AI Companies Can Now List: The fifth set of listing criteria, which previously only applied to biomedicine, has been extended to AI companies. This means that AI startups that are burning money on large-scale models and have not yet made a profit can now raise funds through the STAR Market.
2. From Industry Classification to Technology-Based Segmentation: Frontier fields such as quantum technology and bio-manufacturing have been formally included in the high-tech category, along with a dynamic technology evaluation system. This shift from industry-based to technology-based selection makes the process more accurate and prevents fake tech companies from profiting from the system.
III. Challenges Faced by Frontier Tech Companies in Listing
Despite the reforms, there are still difficulties:
- Valuation Issues: It’s hard to value high-tech companies accurately, especially those in emerging fields like embodied intelligence. The price of their shares (e.g., a PS ratio of 30:1) often relies on speculative assumptions about future applications.
- Early-Stage Financing Hurdles: Venture capitalists (VCs) are hesitant to invest in seed rounds due to limited exit options, preferring to fund later-stage projects. Additionally, performance-based agreements (such as requiring profitability within a set period) deter companies from investing heavily in R&D.
Experts recommend establishing a technology evaluation system, creating mechanisms for capital flow, and developing financial instruments (e.g., technology-related options) that make technical risks more tradable.
IV. Facilitating Capital Flow: From Seed Rounds to Listing
To enable tech companies to secure funding throughout their development, several issues need to be addressed:
- Enhancing Collateral: High-tech companies often lack collateral; patent pledges could increase their borrowing capabilities.
- Progressive Financing: Implement milestone-based financing agreements where investors provide funds based on company achievements (e.g., product development or breakthroughs).
- Exit Mechanisms: Establish clear mechanisms for companies that fail to make progress in core technologies, ensuring capital is not wasted.
V. Finance as a “Patient Gardener”
The role of finance in supporting technology innovation is evolving:
- From a Passive Provider of Funds: To a Catalyst and Ecosystem Builder.
- To Fostering Patient Capital: By attracting long-term investors (e.g., pension funds) and developing tools to monetize intellectual assets, finance can support technology development over the long term.
Experts compare finance to a gardener who nurtures growth rather than using hormones to force rapid growth. Only with patient investment can tech companies focus on sustained innovation.
In summary, while the STAR Market has made significant progress in supporting high-tech companies, further reforms are needed to overcome capital-related barriers and create a sustainable ecosystem for long-term innovation.